INOZYME PHARMA, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 54 rows, 54 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-07-28: Reporting owner Novo Holdings A/S; Form 4; Security SERIES A CONVERTIBLE PREFERRED STOCK; Transaction C Conversion of derivative security.
- 2020-07-28: Reporting owner Novo Holdings A/S; Form 4; Security SERIES A-2 CONVERTIBLE PREFERRED STOCK; Transaction C Conversion of derivative security.
- 2020-07-28: Reporting owner Sanofi; Form 4; Security Series A Convertible Preferred Stock (par value, $0.0001); Transaction C Conversion of derivative security.
- 2020-07-28: Reporting owner Rock Springs Capital LLC | Rock Springs Capital Management LP | Rock Springs Capital Master Fund LP; Form 4; Security Series A-2 Convertible Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-07-28 | Novo Holdings A/S 10% Owner | 4 | SERIES A CONVERTIBLE PREFERRED STOCK Derivative · Direct | C Conversion of derivative security | −15,000,000 0 owned after | no price filed | 2020-07-29 | |
| 2020-07-28 | Novo Holdings A/S 10% Owner | 4 | SERIES A-2 CONVERTIBLE PREFERRED STOCK Derivative · Direct | C Conversion of derivative security | −1,398,600 0 owned after | no price filed | 2020-07-29 | |
| 2020-07-28 | Sanofi 10% Owner | 4 | Series A Convertible Preferred Stock (par value, $0.0001) Derivative · Indirect · Through its wholly-owned subsidiary, Aventis Inc. | C Conversion of derivative security | −3,279,720 0 owned after | $0.00 | 2020-07-29 | |
| 2020-07-28 | Rock Springs Capital LLC | Rock Springs Capital Management LP | Rock Springs Capital Master Fund LP 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −3,496,504 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | Kolchinsky Peter | Shah Rajeev M. | RA CAPITAL MANAGEMENT, L.P. 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −10,489,510 0 owned after | no price filed | 2020-07-28 | |
| 2020-07-28 | New Enterprise Associates 15, L.P. | NEA Partners 15, L.P. | NEA 15 GP, LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,000,533 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | New Enterprise Associates 15, L.P. | NEA Partners 15, L.P. | NEA 15 GP, LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Direct | C Conversion of derivative security | −187,156 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | Tammenoms Bakker Juliet | Longitude Capital Partners III, LLC | ENRIGHT PATRICK G | Longitude Venture Partners III, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · By Longitude Venture Partners III, L.P. | C Conversion of derivative security | −15,000,000 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | Tammenoms Bakker Juliet | Longitude Capital Partners III, LLC | ENRIGHT PATRICK G | Longitude Venture Partners III, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Preferred Stock Derivative · Indirect · By Longitude Venture Partners III, L.P. | C Conversion of derivative security | −1,398,600 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | Jungles Steven J Officer (See Remarks) | 4 | Series A Convertible Preferred Stock Derivative · Indirect · By Steven Jungles Trust Dated Nov. 12, 2014 | C Conversion of derivative security | −100,000 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | Pivotal bioVenture Partners Fund I G.P., L.P. | Pivotal bioVenture Partners Fund I, L.P. | Pivotal bioVenture Partners Fund I U.G.P., Ltd 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −10,489,510 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | Schlessinger Joseph 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −100,000 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | Hopfner Robert Lorne Director, 10% Owner | 4 | Series A-2 Convertible Preferred Stock Derivative · Indirect · By Pivotal bioVenture Partners Fund I, L.P. | C Conversion of derivative security | −10,489,510 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | ALEXION PHARMACEUTICALS, INC. 10% Owner | 4 | Series A-2 Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −8,294,360 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-28 | HEALY JAMES | Katabi Maha | Sofinnova Venture Partners X, L.P. | POWELL MICHAEL | Sofinnova Management X, L.L.C. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −11,888,112 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | Sonsini Peter W. 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −2,000,533 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | Sonsini Peter W. 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −187,156 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | SANDELL SCOTT D 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −2,000,533 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | SANDELL SCOTT D 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −187,156 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | MAKOWER JOSHUA 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −2,000,533 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | MAKOWER JOSHUA 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −187,156 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | Makhzoumi Mohamad 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −2,000,533 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | Makhzoumi Mohamad 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −187,156 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | Florence Anthony A. Jr. 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −2,000,533 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | Florence Anthony A. Jr. 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −187,156 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | BASKETT FOREST 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −2,000,533 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-25 | BASKETT FOREST 10% Owner | 4 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | C Conversion of derivative security | −187,156 0 owned after | $0.00 | 2020-07-28 | |
| 2020-07-23 holding as of filing | ALEXION PHARMACEUTICALS, INC. 10% Owner | 3 | Series A-2 Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Hopfner Robert Lorne Director, 10% Owner | 3 | Series A-2 Convertible Preferred Stock Derivative · Indirect · By Pivotal bioVenture Partners Fund I, L.P. | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Jungles Steven J Officer (See Remarks) | 3 | Series A Convertible Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Rock Springs Capital Master Fund LP | Rock Springs Capital LLC | Rock Springs Capital Management LP 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Katabi Maha | Sofinnova Venture Partners X, L.P. | HEALY JAMES | POWELL MICHAEL | Sofinnova Management X, L.L.C. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Longitude Capital Partners III, LLC | Longitude Venture Partners III, L.P. | Tammenoms Bakker Juliet | ENRIGHT PATRICK G 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Convertible Preferred Stock Derivative · Indirect · By Longitude Venture Partners III, L.P. | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Longitude Capital Partners III, LLC | Longitude Venture Partners III, L.P. | Tammenoms Bakker Juliet | ENRIGHT PATRICK G 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Preferred Stock Derivative · Indirect · By Longitude Venture Partners III, L.P. | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Schlessinger Joseph 10% Owner | 3 | Series A Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Sonsini Peter W. 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Sonsini Peter W. 10% Owner | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | SANDELL SCOTT D 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | SANDELL SCOTT D 10% Owner | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | MAKOWER JOSHUA 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | MAKOWER JOSHUA 10% Owner | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Makhzoumi Mohamad 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Makhzoumi Mohamad 10% Owner | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Florence Anthony A. Jr. 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Florence Anthony A. Jr. 10% Owner | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | BASKETT FOREST 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | BASKETT FOREST 10% Owner | 3 | Series A-2 Preferred Stock Derivative · Indirect · See Note 2 | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | NEA Partners 15, L.P. | New Enterprise Associates 15, L.P. | NEA 15 GP, LLC 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | NEA Partners 15, L.P. | New Enterprise Associates 15, L.P. | NEA 15 GP, LLC 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Preferred Stock Derivative · Direct | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Novo Holdings A/S 10% Owner | 3 | SERIES A CONVERTIBLE PREFERRED STOCK Derivative · Direct | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Novo Holdings A/S 10% Owner | 3 | SERIES A-2 CONVERTIBLE PREFERRED STOCK Derivative · Direct | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Pivotal bioVenture Partners Fund I, L.P. | Pivotal bioVenture Partners Fund I U.G.P., Ltd | Pivotal bioVenture Partners Fund I G.P., L.P. 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | Sanofi 10% Owner | 3 | Series A Convertible Preferred Stock (par value, $0.0001) Derivative · Indirect · Through its wholly-owned subsidiary, Aventis Inc. | Holding | no price filed | 2020-07-23 | ||
| 2020-07-23 holding as of filing | RA CAPITAL MANAGEMENT, L.P. | Kolchinsky Peter | Shah Rajeev M. 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2020-07-23 |